94 related articles for article (PubMed ID: 7529517)
1. Enhancement of lymphokine-activated killer cell cytotoxicity implicated by surface adhesion molecule expression on tumor cell lines pretreated with anti-cancer agents.
Ishihata R; Okubo M; Kasukawa R
Acta Oncol; 1994; 33(8):979-80. PubMed ID: 7529517
[No Abstract] [Full Text] [Related]
2. Enhancement of lymphokine-activated killer cell cytotoxicity implicated in the increased expression of surface adhesion molecules on tumor cells treated with anticancer agents.
Ishihata R; Ejiri Y; Okubo M; Ohara M; Kasukawa R
Cancer Invest; 1996; 14(5):427-34. PubMed ID: 8816858
[TBL] [Abstract][Full Text] [Related]
3. Interferon gamma enhances lymphokine-activated killer cell adhesion but not lysis of head and neck squamous cell carcinoma.
Scher RL; Carras A; Schwab D; Richtsmeier WJ; Koch WM
Arch Otolaryngol Head Neck Surg; 1995 Nov; 121(11):1271-5. PubMed ID: 7576474
[TBL] [Abstract][Full Text] [Related]
4. The high lysability by LAK cells of colon-carcinoma cells resistant to doxorubicin is associated with a high expression of ICAM-1, LFA-3, NCA and a less-differentiated phenotype.
Rivoltini L; Cattoretti G; Arienti F; Mastroianni A; Melani C; Colombo MP; Parmiani G
Int J Cancer; 1991 Mar; 47(5):746-54. PubMed ID: 1706327
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility of acute myelogenous leukemia blasts to lysis by lymphokine-activated killer (LAK) cells and its clinical relevance.
Archimbaud E; Thomas X; Campos L; Fiere D; Doré JF
Leuk Res; 1992; 16(6-7):673-80. PubMed ID: 1378919
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of cell adhesion molecules CD54/CD11a and CD58/CD2 by human melanoma cells and functional role in their interaction with cytotoxic cells.
Altomonte M; Gloghini A; Bertola G; Gasparollo A; Carbone A; Ferrone S; Maio M
Cancer Res; 1993 Jul; 53(14):3343-8. PubMed ID: 7686816
[TBL] [Abstract][Full Text] [Related]
7. Induction of intercellular adhesion molecule 1 on small cell lung carcinoma cell lines by gamma-interferon enhances spontaneous and bispecific anti-CD3 x antitumor antibody-directed lymphokine activated killer cell cytotoxicity.
Azuma A; Yagita H; Matsuda H; Okumura K; Niitani H
Cancer Res; 1992 Sep; 52(18):4890-4. PubMed ID: 1381273
[TBL] [Abstract][Full Text] [Related]
8. Modulating effect of mitomycin or cisplatin on lymphokine-activated killer cell proliferation and antitumor activity to bladder cancer cell lines in vitro.
Wang ZP; Qing DS; Shi BG; Chen YR; Liu GD
Zhongguo Yao Li Xue Bao; 1998 Jul; 19(4):369-72. PubMed ID: 10375787
[TBL] [Abstract][Full Text] [Related]
9. CD10/common acute lymphoblastic leukemia-associated antigen and adhesion factor expression is predictive for lymphokine-activated killing sensitivity of adult B-lineage acute lymphoblastic leukemia.
Correale P; Tagliaferri P; Camera A; Caraglia M; Del Vecchio L; De Laurentis M; Pinto A; Rotoli B; Bianco AR
Year Immunol; 1993; 7():90-5. PubMed ID: 7690510
[No Abstract] [Full Text] [Related]
10. Role of adhesion molecules in lymphokine-activated killer cell killing of bladder cancer cells: further evidence for a third ligand for leucocyte function-associated antigen-1.
Jackson AM; Alexandrov AB; Prescott S; James K; Chisholm GD
Immunology; 1992 Jun; 76(2):286-91. PubMed ID: 1353063
[TBL] [Abstract][Full Text] [Related]
11. Potential role for non-HLA-restricted cytotoxic cells in the immune surveillance of acute leukemia.
Archimbaud E; Campos L; Vila L; Thomas X
Immunol Lett; 1993 Dec; 39(1):13-5. PubMed ID: 7511562
[TBL] [Abstract][Full Text] [Related]
12. Altered expression of P-glycoprotein and cellular adhesion molecules on human multi-drug-resistant tumor cells does not affect their susceptibility to NK- and LAK-mediated cytotoxicity.
Scheper RJ; Dalton WS; Grogan TM; Schlosser A; Bellamy WT; Taylor CW; Scuderi P; Spier C
Int J Cancer; 1991 Jun; 48(4):562-7. PubMed ID: 1710609
[TBL] [Abstract][Full Text] [Related]
13. All-trans retinoic acid decreases susceptibility of a gastric cancer cell line to lymphokine-activated killer cytotoxicity.
Chao TY; Jiang SY; Shyu RY; Yeh MY; Chu TM
Br J Cancer; 1997; 75(9):1284-90. PubMed ID: 9155047
[TBL] [Abstract][Full Text] [Related]
14. ICAM-1 expression by lung cancer cell lines: effects of upregulation by cytokines on the interaction with LAK cells.
Melis M; Spatafora M; Melodia A; Pace E; Gjomarkaj M; Merendino AM; Bonsignore G
Eur Respir J; 1996 Sep; 9(9):1831-8. PubMed ID: 8880099
[TBL] [Abstract][Full Text] [Related]
15. Adhesion molecule-mediated signals regulate major histocompatibility complex-unrestricted and CD3/T cell receptor-triggered cytotoxicity.
Galandrini R; Albi N; Zarcone D; Grossi CE; Velardi A
Eur J Immunol; 1992 Aug; 22(8):2047-53. PubMed ID: 1379184
[TBL] [Abstract][Full Text] [Related]
16. Combined effect of cisplatin and lymphokine-activated killer cells on A549 cells of non-small cell lung cancer.
Zhukova OS; Gerasimova GK; Shubina IZh; Kiselevskii MV
Bull Exp Biol Med; 2007 Aug; 144(2):231-4. PubMed ID: 18399288
[TBL] [Abstract][Full Text] [Related]
17. Effect of human interleukin 3 on the susceptibility of fresh leukemia cells to interleukin-2-induced lymphokine activated killing activity.
Cesano A; Lista P; Bellone G; Geuna M; Brizzi MF; Rossi PR; Pegoraro L; Oberholtzer E; Matera L
Leukemia; 1992 Jun; 6(6):567-73. PubMed ID: 1376379
[TBL] [Abstract][Full Text] [Related]
18. Modulation by cis-diamminedichloroplatinum (II) of the susceptibilities of human T24 lined and freshly separated autologous urinary bladder transitional carcinoma cells to peripheral blood lymphocytes and lymphokine activated killer cells.
Mizutani Y; Nio Y; Yoshida O
J Urol; 1992 Feb; 147(2):505-10. PubMed ID: 1732632
[TBL] [Abstract][Full Text] [Related]
19. Tiazofurin induces a down-modulation of ICAM-1 expression on K562 target cells impairing NK adhesion and killing.
Zamai L; Zauli G; Bavelloni A; Marmiroli S; Cataldi A; Weber G; Vitale M
Cell Immunol; 1995 Aug; 164(1):100-4. PubMed ID: 7543370
[TBL] [Abstract][Full Text] [Related]
20. Induction of ICAM-1 and LFA-3 by Tax1 of human T-cell leukemia virus type 1 and mechanism of down-regulation of ICAM-1 or LFA-1 in adult-T-cell-leukemia cell lines.
Tanaka Y; Fukudome K; Hayashi M; Takagi S; Yoshie O
Int J Cancer; 1995 Feb; 60(4):554-61. PubMed ID: 7530239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]